GENE ONLINE|News &
Opinion
Blog

HIV
Gilead, Merck Unite to Contest ViiV’s Cabenuva with Long-Acting HIV Therapy
2021-03-16
Gilead Reports FDA-Approved HIV Therapy Demonstrates Long-Term Efficacy
2021-03-11
Gilead Aspires to Prolong Leadership in HIV Market, Launches Therapeutic Vaccine Quest with Gritstone
2021-02-03
Game-Changing Antiretroviral Regimen from ViiV Receives FDA Approval
2021-01-22
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
ViiV Healthcare’s Two Drug Regimen Shows Promising Results in HIV-1 Patients
2020-10-06
Merck Reports Higher Efficacy for Islatravir Doravirine Combo in Adults with HIV-1 Infection
2020-07-09
Long-Acting Cabotegravir Injection Performs Better as an HIV PrEP than Daily Pills
2020-05-22
Weekly Cover : Fosun and BioNTech Invest USD 135m for Covid-19 Vaccine
2020-03-19
Kainos Medicine’s New HIV Drug Kicks Off Phase III Trial in China
2020-03-05
‘CRISPR Babies’ Researchers Given Prison Sentence by Chinese Court
2019-12-30
HIV
Weekly in Asia 2019|AUG-1
2019-08-17
Weekly in Asia 20190526-0601
2019-06-05
Update on Tuberculosis containment using vaccine – Taming the disease
2018-10-26
Long term HIV suppression by new combination therapy
2018-10-01
1 2 3
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top